Successful maternal and fetal outcome in a kidney transplant patient with everolimus exposure throughout pregnancy: A case report

Transplantation Proceedings

Volumn 46, Issue 1, 2014, Pages 281-283

  Margoles, H R ^a   Gomez Lobo, V ^b   Veis, J H ^a   Sherman, M J ^a   Moore Jr , J ^c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN; TACROLIMUS; VITAMIN; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; APGAR SCORE; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CESAREAN SECTION; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; END STAGE RENAL DISEASE; ESSENTIAL HYPERTENSION; EVENING DOSAGE; FEMALE; FETUS; FETUS MONITORING; FETUS OUTCOME; FEVER; FOLLOW UP; GESTATIONAL AGE; HEMODIALYSIS; HISPANIC; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIVING DONOR; MALE; MECONIUM ASPIRATION; MEDICAL HISTORY; MORNING DOSAGE; NEPHRITIS; NEWBORN INTENSIVE CARE; OBSTETRIC PROCEDURE; PATIENT REFERRAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PUERPERIUM; PYELONEPHRITIS; VAGINAL DELIVERY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; COMPLICATION; ENVIRONMENTAL EXPOSURE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NEWBORN; PATIENT SAFETY; PREGNANCY COMPLICATION; RISK; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MATERNAL EXPOSURE; PATIENT SAFETY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK; SIROLIMUS; TREATMENT OUTCOME;

EID: 84893608921     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.09.029     Document Type: Article

References (11)

1. D.B. McKay, and M.A. Josephson Pregnancy in recipients of solid organs - Effects on mother and child N Eng J Med 354 2006 1281 1293
2. D.B. McKay, and M.A. Josephson Pregnancy after kidney transplantation Clin J Am Soc Nephrol 3 2008 S117 S125
3. M. Framarino dei Malatesta, L.E. Corona, and L. De Luca et al. Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation Transplantation 91 9 2011 e69 e71
4. M. Veroux, D. Corona, and P. Veroux Pregnancy under everolimus-based immunosuppression Transplant Int 24 2011 e115 e117
5. P. Carta, L. Caroti, and M. Zanazzi Pregnancy in a kidney transplant patient treated with everolimus Am J Kidney Dis 60 2 2012 329
6. S.H. Chu, K.L. Liu, and Y.J. Chiang et al. Sirolimus used during pregnancy in a living related renal transplant recipient: A case report Transplant Proc 40 2008 2446 2448
7. C. Gurk-Turner, W. Manitpisitkul, and M. Cooper A comprehensive review of everolimus clinic reports: A new mammalian target of rapamycin inhibitor Transplantation 94 2012 659 668
8. N.M. Sifonis, L.A. Coscia, and S. Constantinescu et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus Transplantation 82 2006 1698 1702
9. I. Jankowska, U. Oldakowska-Jedynak, and Z. Jabiry-Zieniewicz et al. Absence of teratogenicity of sirolimus during early pregnancy in a liver transplant recipient Transplant Proc 36 2004 3232 3233
10. O. Guardia, M.C. del Rial, and D. Casadei Pregnancy under sirolimus-based immunosuppression Transplantation 81 2006 636
11. L.A. Coscia, S. Constantinescu, and M.J. Moritz et al. Report from the national transplantation pregnancy registry (NPTR): Outcomes of pregnancy after transplantation Clin Transpl 2010 65 85